What is QDEL's market cap?

$984.06M, based on the Nov 4 close of $14.35.

Does QuidelOrtho pay a dividend?

No regular cash dividend has been paid in the last year.

How much of QDEL is sold short?

13.0M shares, 19.2% of float, as of Oct 15, 2026.

What sector is QDEL in?

Healthcare, in the Diagnostics industry.

NASDAQ · QDELHealthcareDiagnostics

QuidelOrtho Corporation Common Stock (QDEL)

$14.35+1.85%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$14.35▼ 47.11% in range

Nov 4, 2025Low $9.96 · High $35.38Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

QuidelOrtho closed at $14.35 on Nov 4, up 1.85%, 59.4% below its 52-week closing high. Volume of 3.3M shares was 1.42× its 20-day average (above normal).

Split-adjusted performance: +14.2% over one month, +30.9% over six months, -48.2% over one year.

In the quarter ended Jun 28, 2026, revenue was $630.90M, up 2.8% from a year earlier, with a net margin of -14.7%.

Short interest was 13.0M shares at the Oct 15 settlement, down 13.1% from the prior report (19.2% of float, 4.9 days to cover).

Market cap$984.1M68.6M shares

Revenue · quarter$630.9M+2.8% YoY

Diluted EPS$-1.36—

P/E · TTM—P/S 0.4×

Net margin-14.7%Gross 43.3%

Dividend yieldNone

52-week range9.96 – 35.38−59.4% from high

Volume3.3M1.42× 20-day avg

Volatility · 60d65.8%Annualised

Short % of float19.2%4.9 days to cover

Net cash-$2.77BCash $123.4M

Next earnings—Not scheduled

Split-adjusted performance

1W +2.4%1M +14.2%3M −12.1%6M +30.9%YTD −49.8%1Y −48.2%3Y −76.1%5Y −89.2%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Diagnostics

Percentile among 15 companies (100 = best)

6-month momentum71

Revenue growth67

Net margin67

Value (low P/E)—

Size64

Industry medians: 6-month return +17.4%, revenue growth −2.0%, net margin −26.0%, P/E 46.6×.

Short interest

Details →

Shares short13.0M−13.1% vs prior

Days to cover4.9Settled Oct 15

% of float19.2%

Short vol. 10d41.8%of daily volume

Closest peers by size in Diagnostics

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
QDELQuidelOrtho	$14.35	+1.85%	+30.9%	+2.8%	−14.7%	—	$984.1M
ACHVAchieve Life Sciences	$6.98	+3.71%	+45.4%	—	—	—	$719.7M	Compare
MYGNMyriad Genetics	$6.02	−0.33%	+46.5%	−10.5%	−22.7%	—	$575.8M	Compare
NTLAIntellia Therapeutics	$12.31	+3.79%	−11.1%	−46.2%	−1392.3%	—	$1.72B	Compare
TKNOAlpha Teknova	$7.37	+0.41%	+102.5%	+18.5%	−26.0%	—	$454.7M	Compare
CLDXCelldex Therapeutics	$29.93	+0.74%	−13.0%	−97.0%	−334104.5%	—	$2.35B	Compare
NEOGNeogen	$12.46	+2.98%	+35.7%	+6.5%	−5.3%	—	$2.72B	Compare
LNTHLantheus Holdings	$101.14	+0.34%	+17.4%	+2.7%	19.3%	24.0	$6.60B	Compare
ICCCImmucell	$10.37	+1.17%	+19.7%	+11.5%	25.5%	119.6	$94.2M	Compare

News about QuidelOrtho

All news →

QuidelOrtho (QDEL) Beats Q3 Earnings and Revenue EstimatesZacks Investment Research · 1d ago▼ Negative Reasons to Add QuidelOrtho Stock to Your Portfolio for NowZacks Investment Research · Oct 14, 2026▲ Positive Rice Hall James Buys QuidelOrtho StockThe Motley Fool · Mar 9, 2026▲ Positive QuidelOrtho Corp Director Purchases 10k Shares as CFO RetiresThe Motley Fool · Mar 2, 2026▼ Negative

Quick answers

What does QuidelOrtho do?: QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe.
What is QDEL's market cap?: $984.06M, based on the Nov 4 close of $14.35.
Does QuidelOrtho pay a dividend?: No regular cash dividend has been paid in the last year.
How much of QDEL is sold short?: 13.0M shares, 19.2% of float, as of Oct 15, 2026.
What sector is QDEL in?: Healthcare, in the Diagnostics industry.

About QuidelOrtho

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.

HQ: San Diego, CA6,500 employeesListed Aug 4, 1981quidelortho.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology